0
ARTICLE |

OBSERVATIONS ON THE TOPICAL USE OF SULFONAMIDE DERIVATIVES

EDGAR M. BICK, M.D.
JAMA. 1942;118(7):511-513. doi:10.1001/jama.1942.02830070017005.
Text Size: A A A
Published online

The ability of the sulfonamide derivatives to prevent infections in wounds when applied locally has now become well established. The fact has been repeatedly demonstrated in experimental, operative and traumatic lesions and has been fully reported.1 It is possible by means of such topical application to create not only a high concentration of the drug in the tissue fluids surrounding the lesion but to maintain a degree of hemoconcentration varying from 3 to 4 mg. per hundred cubic centimeters in twenty-four hours to a residual trace a week later following the use of 10 to 15 Gm. in large wounds. While a hemoconcentration at this level is hardly sufficient to combat an established septicemia of any real intensity, it is apparently high enough to prevent its development from a properly treated contaminated wound. The subject is now sufficiently advanced that generalizations on end results in terms of gross infection

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs